Which pharmaceutical giant rebranded from 'Phillip Morris' to its current name in 2003 to distance itself from tobacco associations while maintaining its pharmaceutical operations?

In the competitive pharmaceutical industry, brand identity can significantly impact market perception and consumer trust. When major pharmaceutical companies undergo rebranding, it often signals strategic shifts in their business approach or an attempt to overcome negative publicity. This poll tests your knowledge about one of the most significant pharmaceutical rebranding efforts in recent history, which helped transform a company's public image following controversy.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Altria Group (while keeping Phillip Morris as a subsidiary)
Pfizer (formerly combined tobacco and pharmaceuticals)
Novartis (separated from its tobacco division)
GlaxoSmithKline (divested tobacco interests in rebranding)